Back to School: How biopharma can reboot drug development. Access exclusive analysis here

0910 Korro Bio
BioCentury & Getty Images

Finance

Korro Bio’s $91.5M series A brings in new investors, launches hunt for CEO

Sep 10, 2020 | 10:52 PM GMT

Korro Bio’s $91.5 million series A round opens the door to new leadership for the Atlas-built

Read the full 414 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE